45至74岁主动脉瓣置换:机械瓣与生物瓣的远期结局
该多中心研究纳入1989至2019年4家医疗中心5762例45至74岁行主动脉瓣置换(伴或不伴冠状动脉旁路移植)的患者,比较机械瓣与生物瓣的远期结局。生物瓣组校正后死亡风险更高(HR 1.30,P < .001),机械瓣的生存获益持续至70岁;两组卒中风险相似,生物瓣大出血风险更低、再手术风险更高。
要点
- 生物瓣组校正后远期死亡风险高于机械瓣组(HR 1.30,P < .001)。
- 机械瓣相关的长期生存获益持续至70岁。
- 生物瓣较机械瓣大出血风险更低、再手术风险更高,卒中风险相似。
核心结论
- 与生物瓣相比,机械主动脉瓣与70岁及以下患者更低的校正长期死亡风险相关。
- 70岁以下行外科主动脉瓣置换的患者应被告知机械瓣替代物的潜在生存获益。
研究设计与样本
- 多中心研究,纳入1989至2019年4家医疗中心5762例45至74岁行生物瓣或机械瓣主动脉瓣置换(伴或不伴冠状动脉旁路移植)的患者。
- 采用Cox比例风险模型比较远期生存,并以年龄与瓣膜类型的交互项评估年龄依赖效应。
主要发现
- 61%(n = 3508)的患者接受生物瓣。
- 30天死亡率生物瓣组1.7%(n = 58)vs 机械瓣组1.5%(n = 34),P = .75。
- 平均随访9.0年,校正后死亡风险生物瓣组更高(HR 1.30,P < .001)。
- 机械瓣相关的长期生存获益持续至70岁。
- 生物瓣(vs 机械瓣)卒中风险相似(P = .20),大出血风险更低(P < .001),再手术风险更高(P < .001)。
临床怎么用
- 对70岁及以下拟行外科主动脉瓣置换的患者,应告知机械瓣可能带来的生存获益。
- 瓣膜选择需结合患者年龄,并权衡卒中、大出血与再手术风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The selection of valve prostheses for patients undergoing surgical aortic valve replacement remains controversial. In this study, we compared the long-term outcomes of patients undergoing aortic valve replacement with biological or mechanical aortic valve prostheses. METHODS: We evaluated late results among 5762 patients aged 45 to 74 years who underwent biological or mechanical aortic valve replacement with or without concomitant coronary artery bypass from 1989 to 2019 at 4 medical centers. The Cox proportional hazards model was used to compare late survival; the age-dependent effect of prosthesis type on long-term survival was evaluated by an interaction term between age and prosthesis type. Incidences of stroke, major bleeding, and reoperation on the aortic valve after the index procedure were compared between prosthesis groups. RESULTS: Overall, 61% (n = 3508) of patients received a bioprosthesis. The 30-day mortality rate was 1.7% (n = 58) in the bioprosthesis group and 1.5% (n = 34) in the mechanical group (P = .75). During a mean follow-up of 9.0 years, the adjusted risk of mortality was higher in the bioprosthesis group (hazard ratio, 1.30, P < .001). The long-term survival benefit associated with mechanical prosthesis persisted until 70 years of age. Bioprosthesis (vs mechanical prosthesis) was associated with a similar risk of stroke (P = .20), lower risk of major bleeding (P < .001), and higher risk of reoperation (P < .001). CONCLUSIONS: Compared with bioprostheses, mechanical aortic valves are associated with a lower adjusted risk of long-term mortality in patients aged 70 years or less. Patients aged less than 70 years undergoing surgical aortic valve replacement should be informed of the potential survival benefit of mechanical valve substitutes.
引用
- Sun D, Schaff HV, Greason KL, et al. Mechanical or biological prosthesis for aortic valve replacement in patients aged 45 to 74 years. J Thorac Cardiovasc Surg. 2024. PMID: 38960283. doi:10.1016/j.jtcvs.2024.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。